Weighted Average Number of Shares Outstanding, Basic of 10x Genomics, Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
10x Genomics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2019 to Q3 2025.
  • 10x Genomics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 126M shares, a 3.95% increase year-over-year.
  • 10x Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 120M shares, a 2.81% increase from 2023.
  • 10x Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 117M shares, a 2.9% increase from 2022.
  • 10x Genomics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 114M shares, a 3.18% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

10x Genomics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 126M +4.77M +3.95% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 124M +3.69M +3.07% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 123M +3.21M +2.69% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025
Q4 2024 120M +3.29M +2.81% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2025
Q3 2024 121M +3M +2.55% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 120M +3.36M +2.88% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025
Q1 2024 119M +3.77M +3.26% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025
Q4 2023 117M +3.31M +2.9% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2025
Q3 2023 118M +3.62M +3.17% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024
Q2 2023 117M +3.13M +2.76% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 116M +2.65M +2.35% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024
Q4 2022 114M +3.51M +3.18% 01 Oct 2022 31 Dec 2022 10-K 13 Feb 2025
Q3 2022 114M +3.24M +2.92% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 114M +3.71M +3.38% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 113M +4.25M +3.91% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 110M +9.2M +9.09% 01 Oct 2021 31 Dec 2021 10-K 15 Feb 2024
Q3 2021 111M +9.53M +9.41% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 110M +10.9M +11% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 109M +11.9M +12.3% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 101M 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2023
Q3 2020 101M 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021
Q2 2020 99M 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 96.8M 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021

10x Genomics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 120M +3.29M +2.81% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025
2023 117M +3.31M +2.9% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025
2022 114M +3.51M +3.18% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025
2021 110M +9.2M +9.09% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024
2020 101M +62.1M +159% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023
2019 39.1M 01 Jan 2019 31 Dec 2019 10-K 18 Feb 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.